Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$101.21 - $166.61 $2,732 - $4,498
-27 Reduced 1.19%
2,248 $266,000
Q1 2024

Apr 17, 2024

SELL
$85.37 - $115.44 $1,792 - $2,424
-21 Reduced 0.91%
2,275 $242,000
Q4 2023

Jan 11, 2024

BUY
$69.51 - $104.43 $159,594 - $239,771
2,296 New
2,296 $228,000
Q1 2023

Apr 27, 2023

SELL
$135.66 - $197.02 $2,306 - $3,349
-17 Reduced 1.28%
1,307 $200,000
Q4 2022

Jan 27, 2023

BUY
$118.38 - $210.04 $156,735 - $278,092
1,324 New
1,324 $0
Q4 2020

Mar 05, 2021

SELL
$65.74 - $169.86 $30,700 - $79,324
-467 Closed
0 $0
Q3 2020

Nov 19, 2020

BUY
$54.34 - $94.85 $25,376 - $44,294
467 New
467 $33,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Jeppson Wealth Management, LLC Portfolio

Follow Jeppson Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jeppson Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jeppson Wealth Management, LLC with notifications on news.